Vaxart, Inc. Other Non-Current Liabilities
Vaxart, Inc. (VXRT) had Other Non-Current Liabilities of $872.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Noncurrent $872.00K.
- 2026-03-31: Other Liabilities, Noncurrent $841.00K.
- 2025-12-31: Other Liabilities, Noncurrent $817.00K.
- 2025-09-30: Other Liabilities, Noncurrent $489.00K.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $872.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $841.00K S-1 · filed 2026-05-08 | |
| 2025-12-31 | $817.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $489.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $472.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $455.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $439.00K S-1 · filed 2026-05-08 | |
| 2024-09-30 | $421.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $405.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $309.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $293.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $278.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $262.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $246.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $231.00K 10-K · filed 2024-03-14 | |
| 2022-09-30 | $216.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $201.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $186.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $171.00K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $156.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $142.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $122.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $109.00K 10-K · filed 2022-02-24 | |
| 2020-06-30 | $18.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $18.00K 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $18.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $18.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $18.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $18.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $157.00K 10-K · filed 2020-03-19 | |
| 2017-12-31 | $100.00K 10-Q · filed 2018-02-06 | |
| 2017-09-30 | $100.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $100.00K 10-Q · filed 2018-02-06 | |
| 2017-03-31 | $200.00K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $200.00K 10-Q · filed 2017-02-06 | |
| 2016-09-30 | $200.00K 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $200.00K 10-K · filed 2017-09-01 | |
| 2016-03-31 | $200.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $200.00K 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $100.00K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $100.00K 10-K · filed 2016-09-13 | |
| 2015-03-31 | $100.00K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $100.00K 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $100.00K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $200.00K 10-K · filed 2015-09-11 | |
| 2014-03-31 | $200.00K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $200.00K 10-Q · filed 2014-02-10 | |
| 2013-09-30 | $300.00K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $200.00K 10-K · filed 2014-09-30 | |
| 2013-03-31 | $296.00K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $275.00K 10-Q · filed 2013-02-11 | |
| 2012-06-30 | $500.00K 10-K · filed 2013-09-27 | $504.00K 10-Q · filed 2013-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |